Catalyst Wire Dossier Catalyst Wire Dossier

Delamanid

delamanid · Otsuka Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Delamanid, covering 2017-09-11 to 2026-08-12. Get the full timeline:

Most recent: Clinical Trial Results: Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB [Phase 2]

See pricing